Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,935 | -9,384 | -6,027 | -5,428 | -3,308 |
| Depreciation Amortization | 898 | 689 | 627 | 476 | 285 |
| Accounts receivable | 47 | -1,080 | 254 | -359 | -88 |
| Other Working Capital | -174 | 23 | 87 | 557 | -518 |
| Other Operating Activity | 10 | 1,157 | -213 | 423 | 384 |
| Operating Cash Flow | $-6,154 | $-8,595 | $-5,272 | $-4,331 | $-3,245 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 6,472 | 4,368 | 4,094 | -17,394 | N/A |
| PPE Investments | -336 | -403 | -419 | -72 | -5 |
| Net Acquisitions | N/A | -1,313 | N/A | N/A | -102 |
| Other Investing Activity | -209 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $5,927 | $2,652 | $3,675 | $-17,466 | $-107 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 600 | 12,615 | N/A |
| Debt Repayment | -784 | -107 | -25 | -26 | -97 |
| Common Stock Repurchased | N/A | N/A | N/A | -754 | N/A |
| Other Financing Activity | 266 | 32 | 33 | 17,508 | 2,831 |
| Financing Cash Flow | $-518 | $-75 | $608 | $29,343 | $2,734 |
| Exchange Rate Effect | 28 | 36 | N/A | N/A | N/A |
| Beginning Cash Position | 1,444 | 7,426 | 8,415 | 869 | 1,487 |
| End Cash Position | 727 | 1,444 | 7,426 | 8,415 | 869 |
| Net Cash Flow | $-717 | $-598 | $-989 | $7,546 | $-618 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,154 | -8,595 | -5,272 | -4,331 | -3,245 |
| Capital Expenditure | -336 | -403 | -419 | -72 | -5 |
| Free Cash Flow | -6,490 | -8,998 | -5,691 | -4,403 | -3,250 |